Viewing Study NCT04690075



Ignite Creation Date: 2024-05-06 @ 3:38 PM
Last Modification Date: 2024-10-26 @ 1:53 PM
Study NCT ID: NCT04690075
Status: UNKNOWN
Last Update Posted: 2021-01-08
First Post: 2020-12-14

Brief Title: Effect of Dietary Fiber on Metabolism Inflammation and Nutritional Status in Patients With Chronic Diseases
Sponsor: Peking Union Medical College Hospital
Organization: Peking Union Medical College Hospital

Study Overview

Official Title: Dietary Fiber in Nutritional Therapy for Chronic Diseases
Status: UNKNOWN
Status Verified Date: 2021-01
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The prevalence of chronic disease is increasing rapidly in China Medical nutritional therapy MNT is essential for the prevention and control of chronic diseases For example dietary fiber plays an important role in chronic disease management Evidence suggests that increasing fiber intake can decrease the risk of chronic diseases such as overweightobesity hyperlipidemia hyperglycemia GI diseases etc However according to the nation-wide survey the dietary fiber intake of Chinese people shows a downward trend in recent years and the relationship between dietary fiber and metabolism of chronic patients is still controversial So this study aims to explore the effects of dietary fiber on metabolism inflammatory factors and nutritional status among patients with chronic diseases so as to provide reference for proper nutrition intervention towards chronic disease
Detailed Description: Investigators plan to recruit potential participants in hospital clinics using posters An anticipated total of 120 patients with chronic diseases including overweight obesity hyperlipemia hyperglycemia etc will be randomized to receive oat beta-glucans study group or routine nutrition management control group respectively The outcome parameters including weight blood glucose level blood fat level etc will be measured and compared over a 12-week intervention period Intention-to-treat analysis ITT and per-protocol analysis PP will be conducted in statistical analysis

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None